Sources and updates, December 4
Sources and updates for the week of December 4 include new CDC grants to support public health infrastructure, breakthrough COVID-19 deaths, monoclonal antibodies, and more.
Read MoreTag: vaccine equity
Sources and updates, November 6
Sources and updates for the week of November 6 include Omicron bivalent boosters, a Long COVID clinical trial, an RSV vaccine, and more.
Read MoreSources and updates, October 23
Sources and updates for the week of October 23 include flu vaccination disparities, genomic surveillance from travelers, hospital finances, and more.
Read MoreCOVID-19 risk factors that should lead to Omicron booster priority
Unlike previous vaccination campaigns, the new Omicron boosters are available to all adults across the country who have been previously inoculated. But all previously-vaccinated Americans are not facing similar levels of COVID-19 risk.
Read MoreSources and updates, July 10
Sources and updates for the week of July 10 include Long COVID data from the CDC, air quality guidance, COVID-19 disparities in Louisiana, and more.
Read MorePandemic preparedness: Improving our data surveillance and communication
What has the U.S. learned from the last two years, and what lessons can we take forward for future COVID-19 surges and other infectious disease outbreaks? The Biden administration has released a new pandemic preparedness plan that addresses these questions.
Read MoreSources and updates, March 6
Sources and updates for the week of March 6 include COVID-19 relief funding in schools, Long COVID estimates, and more.
Read MoreAs COVID-19 precautions are lifted, who remains vulnerable?
As more states and other institutions lift COVID-19 safety measures, the shift has sparked a conversation about who remains most vulnerable to COVID-19 during this period. These vulnerable groups include unvaccinated and unboosted seniors, immunocompromised people, and pregnant people.
Read MoreWe failed to vaccinate the world in 2021; will 2022 be more successful?
In January, COVAX set a goal that many global health advocates considered modest: delivering 2.3 billion vaccine doses to low- and middle-income countries by the end of 2021. is saying it’ll deliver just 800 million vaccine doses by the end of 2021, according to the Washington Post, and only about 600 million had been delivered by early December.
Read MoreOne month into vaccinations for kids 5-11, uptake varies wildly by state
It’s been about a month since the FDA and CDC authorized a version of Pfizer’s vaccine for children ages five to 11. Those kids whose parents immediately took them to get vaccinated are now eligible for their second doses, and will be considered fully vaccinated by Christmas. Despite widespread availability of the shots, vaccine uptake has varied wildly.
Read More